News

Phosphagenics Signs a Multinational License for TPM® in Personal Care Products

Phosphagenics Signs a Multinational License for TPM® in Personal Care Products 4 December 2017, Melbourne: Australian drug delivery company, Phosphagenics Limited (ASX: POH; OTCQX: PPGNY), is pleased to announce the signing of a non-exclusive license agreement with Rodan…

Major $640 million investment in Australia’s world-leading medical research

The Turnbull Government will invest $640 million to support Australia’s world-leading health and medical researchers as they continue their work in the laboratory, clinic and the community to find the next major medical breakthrough. Cancer research continues to…

$33 million for CRC Projects to tackle diverse industry problems 

http://minister.industry.gov.au/ministers/laundy/media-releases/33-million-crc-projects-tackle-diverse-industry-problems?mc_cid=da234fdd4a&mc_eid=1eb046c0f3 Better barramundi breeding, disease resistant bananas, a portable brain scanner for early stroke detection and a process to turn waste plastics into spectacle frames are amongst 15 highly diverse industry-led projects to receive a $33 million investment…

Job: Senior Quality Assurance Manager

• TGA Licensed Manufacturer • Manage department of 38+ staff • Winner of multiple export awards Our Client Our client is an Australian success story experiencing year on year international growth in over 22 countries. Their mission is…

$2.5M GRANT AWARDED TO ADVANCE WOUNDVUE™ DEVELOPMENT

• Joint collaboration with University of Melbourne and Planet Innovation Adelaide, Australia, 7 December 2017: Australian medical technology company, LBT Innovations Limited (ASX:LBT) is pleased to announce it has been awarded a $2.513 million grant to advance the…

Media Release – Industry calls for Medical Technologies and Pharmaceuticals Innovation Hub

Media Release – Monday 20th November 2017 At its Annual General Meeting today, BioMelbourne Network will launch a pre-budget submission calling for the Victorian Government to invest in a Medical Technologies and Pharmaceuticals Innovation Hub in Melbourne. The Hub…

Advertise your job here

BioMelbourne Network member organisations can advertise their job opportunity here by emailing them to info@biomelbourne.org.  Our website receives more than 12,000 unique visitors per month We will also send your job opportunity to the 4,500+ recipients of our…

Prima BioMed has just announced new clinical data from its TACTI-mel Phase I trial in Australia – which is investigating Prima’s lead drug, IMP321, in combination with KEYTRUDA in metastatic melanoma

Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD) (“Prima”) is pleased to announce the presentation of new data from its TACTI-mel Phase I clinical trial in Australia investigating the use of eftilagimod alpha (LAG-3Ig or IMP321), the Company’s lead…

IDT Australia Executes API Development Agreement

• API Development Agreement executed with The State Government of Victoria • Total consideration over AUD 2,000,000 over the twelve month term of the project Australian pharmaceutical manufacturing and drug development company IDT Australia Limited (ASX:IDT) announces it…

AdAlta appoints Dr Dallas Hartman as Chief Operating Officer

AdAlta Limited (ASX: 1AD), the biotechnology company advancing its lead i-body candidate towards clinical development, is pleased to announce the appointment of experienced executive, Dr Dallas Hartman to the role of Chief Operating Officer. Dr Hartman will bring…

Patrys and Garvan Institute of Medical Research Awarded Grant

Patrys Limited (ASX: PAB), a clinical stage biotechnology company and Sydney’s Garvan Institute of Medical Research (Garvan) have recently finalized the terms of a Federal Government Innovation Connections grant to support research within the PATDX1 program. The Garvan…

New US patent for Patrys PAT-LM1

Patrys (ASX:PAB), a clinical stage biotechnology company, has been granted a US patent for its anti-cancer pre-clinical candidate PAT-LM1. The US Patent Office has issued correspondence confirming the grant of a key patent in the PAT-LM1 family, patent…

Home

News & opinion

Member Directory

Events